Multiple Factors Involved in B-Cell Tumorigenesis

  • George Klein

Abstract

This chapter considers the hypothesis that activation of the c-myc locus by chromosomal translocation to a site adjacent to one of the immunoglobulin loci represents an essential, rate-limiting step in the development of Burkitt’s lymphoma, mouse plasmacytoma, and rat immunocytoma. It also describes a possible mechanism by which an activated c-myc affects susceptible cells, as well as additional factors which may contribute to the acquisition of a malignant phenotype.

Keywords

Lymphoma Leukemia Recombination Oncol Malaria 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Banerjee M, Wiener F, Spira J, Babonits M, Nilsson M-G, Sumegi J, Klein G (1985) Mapping of the c-myc, ptv-1and immunoglobulin kappa genes in relation to the mouse plasmacytomaassociated variant (6;15) translocation breakpoint. EMBO J 4: 3183–3188PubMedGoogle Scholar
  2. Berger R, Bernheim A (1982) Cytogenetic studies on Burkitt’s lymphoma-leukemia. Cancer Gen Cytogen 7:231–244CrossRefGoogle Scholar
  3. Chaganti RSK, Jhanwar SC, Koziner B, Arlin Z, Mertelsman R, Clarkson B (1983) Specific translocations characterize Burkitt’s like lymphoma of homosexual men with the acquired immunodeficiency syndrome. Blood 61:1265–1268PubMedGoogle Scholar
  4. Erikson J, Finan J, Tsujimoto Y, Nowell PC, Croce CM (1984) The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus. Proc Natl Acad Sci USA 81: 4144–4148PubMedCrossRefGoogle Scholar
  5. Erikson J, Finan J, Tsujimoto Y, Nowell PC, Croce CM (1984) The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus. Proc Natl Acad Sci USA 81: 4144–4148PubMedCrossRefGoogle Scholar
  6. Fahrlander PD, Sämegi J, Yang JQ, Wiener F, Marcu KB, Klein G (1985) Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma. Proc Natl Acad Sci USA 82:3746–750PubMedCrossRefGoogle Scholar
  7. Kirsch IR, Morton CC, Nakahara K, Leder P (1982) Human immunoglobulin heavy chain genes map to a region of translocations in malignant B lymphocytes. Science 216: 301–303PubMedCrossRefGoogle Scholar
  8. Klein G (1979) Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci USA 76: 2442–2446PubMedCrossRefGoogle Scholar
  9. Klein G (1981) The role of gene dosage and genetic transpositions in carcinogenesis. Nature 294: 313–318PubMedCrossRefGoogle Scholar
  10. Klein G, Klein E (1984) The changing faces of EBV research. In: Melnick JL, Hummeler K (eds) Prog Med Virol. Karger, Basel, pp 87–106Google Scholar
  11. Klein G, Klein E (1985) Myc/Ig juxtaposition by chromosomal translocations: Some new insights, puzzles and paradoxes. Immunology Today 6: 208–215CrossRefGoogle Scholar
  12. Klein G, Lenoir G (1982) Translocation involving Ig-locus carrying chromosomes: A model for genetic transposition in carcinogenesis. Adv Cancer Res 37: 381–387PubMedCrossRefGoogle Scholar
  13. Manolov G, Manolova Y (1972) Marker band in one chromosome 14 from Burkitt lymphomas. Nature 237:33–34PubMedCrossRefGoogle Scholar
  14. Mitelman F (1981) Marker chromosome 14q + in human cancer and leukemia. Adv Cancer Res 34: 141–170PubMedCrossRefGoogle Scholar
  15. Mitelman M, Anderson-Anvret M, Brandt L, Catovsky D, Klein G, Manolov G, Manolova Y, Mark-Vendel E, Nilsson PG (1979) Reciprocal 8;14 translocation in EBV-negative B-cell acute lymphocytic leukemia with Burkitt-type cells. Int J Cancer 24: 27–33PubMedCrossRefGoogle Scholar
  16. Ohno S, Babonits M, Wiener F, Spira K, Klein G (1979) Non-random chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristane-induced mouse plasmacytomas. Cell 18: 1001–1007PubMedCrossRefGoogle Scholar
  17. Ohno S, Babonits M, Wiener F, Spira K, Klein G (1979) Non-random chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristane-induced mouse plasmacytomas. Cell 18: 1001–1007PubMedCrossRefGoogle Scholar
  18. Pegoraro L, Palumbo A, Erikson J, Falda M, Giovanazzo B, Emanual BS, Rovera G, Novell PC, Croce CM (1984) A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci USA 81: 7166–7170PubMedCrossRefGoogle Scholar
  19. Potter M, Wiener F, Mushinski JF (1984) Recent developments in plasmacytomagenesis in mice. Adv Viral Oncol 4: 139–162Google Scholar
  20. Rowley JD (1977) Mapping of human chromosomal regions related to neoplasia: Evidence from chromosomes 1 and 17. Proc Natl Acad Sci USA 74: 5729–5733PubMedCrossRefGoogle Scholar
  21. Sümegi J, Spira J, Bazin H, Szpirer J, Levan G, Klein G (1983) Rat c-myconcogene is located on chromosome 7 and rearranges in immunocytomas with t(6;7) chromosomal translocation. Nature 306: 497–498PubMedCrossRefGoogle Scholar
  22. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Nature 226:1097–1099Google Scholar
  23. Tsujimoto Y, Cossman J, Croce CM (1985a) Involvement of the bc1–2gene in human follicular lymphoma. Science 228: 1440–1443CrossRefGoogle Scholar
  24. Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM (1985b) Clustering of breakpoints on chromosome 11 in human B-cell neoplasmas with the t(11;14) chromosome translocation. Nature 315: 340–342CrossRefGoogle Scholar
  25. Weinberg RA (1985) The action of oncogenes in the cytoplasm and nucleus. Science 230:770–776PubMedCrossRefGoogle Scholar
  26. Wiener F, Babonits M, Spira J, Klein G, Potter M (1980) Cytogenetic studies on IgA/lambdaproducing murine plasmacytomas: regular occurrence of a T(12;15) translocation. Somatic Cell Gen 6: 731–738CrossRefGoogle Scholar
  27. Wiener F, Babonits M, Bregula U, Klein G, Leonard A, Wax JS, Potter M (1984a) High resolution banding analysis of the involvement of strain Balb/c-and AKR-derived chromosomes no. 15 in plasmacytoma specific translocations. J Exp Med 159: 276–291CrossRefGoogle Scholar
  28. Wiener F, Ohno S, Babonits M, Sümegi J, Wirschubsky Z, Klein G, Mushinski JF, Potter M (1984b) Hemizygous interstitial deletion of chromosome 15 (band D) in three translocation-negative murine plasmacytomas. Proc Natl Acad Sci USA 83: 1159–1163CrossRefGoogle Scholar
  29. Zech L, Haglund U, Nilsson K, Klein G (1976) Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17: 47–56PubMedCrossRefGoogle Scholar
  30. Ziegler JL, Levy JA (1985) Acquired immunodeficiency syndrome and cancer. Adv Virol Oncol 5: 239–255Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • George Klein

There are no affiliations available

Personalised recommendations